Trial
NCT03331666
Impact of LDL-cholesterol Lowering on Platelet Activation
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Amgen
Condition
Familial Hypercholesterolemia
Intervention
Evolocumab
Why stopped
Terminated Prematurely due to COVID-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-01